CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (7)
2022
-
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study
JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377
2021
-
Scoring balloon predilation before bioresorbable vascular scaffold implantation in patients with in-stent restenosis: the RIBS VI 'scoring' study
Coronary artery disease, Vol. 32, Núm. 2, pp. 96-104
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2017
-
Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study
JACC: Cardiovascular Interventions, Vol. 10, Núm. 18, pp. 1841-1851
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Comparison of 1-Year Outcome in Patients with Severe Aorta Stenosis Treated Conservatively or by Aortic Valve Replacement or by Percutaneous Transcatheter Aortic Valve Implantation (Data from a Multicenter Spanish Registry)
American Journal of Cardiology, Vol. 118, Núm. 2, pp. 244-250
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958